Molecule Structure

Scientific Name

Memantine

Description of the Drug

Memantine is an NMDA receptor antagonist used to treat moderate to severe dementia in Alzheimer’s.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01043

Brand Name(s)

Not Available

Company Owner(s)

Jubilant Generics Ltd, Macleods Pharmaceuticals Ltd, Anchen Pharmaceuticals Inc, Yichang Humanwell Pharmaceutical Co Ltd, Chartwell Life Molecules Llc, Amneal Pharmaceuticals Of New York Llc, Allergan Sales Llc, Zydus Pharmaceuticals Usa Inc, Torrent Pharmaceuticals Ltd, Rising Pharma Holdings Inc

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Glutamate [NMDA] receptor PROTEIN COMPLEX GROUP NEGATIVE ALLOSTERIC MODULATOR CHEMBL2094124

Unichem Links

SureChEMBL SCHEMBL2688
PharmGKB PA10364
Human Metabolome Database HMDB0015177
DrugBank DB01043
PubChem: Thomson Pharma 15147301
PubChem 4054
Mcule MCULE-3726352671
LINCS LSM-5154
BindingDB 50062599
EPA CompTox Dashboard DTXSID5045174
DrugCentral 1679
Brenda 72165
ChemicalBook CB7436657 CB22130921
Guide to Pharmacology 4253
rxnorm MEMANTINE HYDROCHLORIDE MEMANTINE NAMENDA
KEGG Ligand C13736
ChEBI 64312